Felbamate and Drospirenone Interaction

Drug interaction information between Felbamate and Drospirenone.

Felbamate and Drospirenone have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Felbamate and Drospirenone. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Felbamate

Anticonvulsant

Drug B

Drospirenone

Combined Oral Contraceptive

How They Interact

Felbamate can cause your body to process birth control hormones faster, which makes the pill less effective at preventing pregnancy.

FDA Label Information

Some drugs or herbal products that may decrease the effectiveness of hormonal contraceptives include phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampin, topiramate and products containing St.

Frequently Asked Questions

What SPL severity band is on file for Felbamate + Drospirenone/Ethinyl Estradiol?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Drospirenone has 30 labeled pairs on file vs Felbamate's 16. In the minor band specifically: Felbamate has 15 (also Erythromycin, Phenobarbital, Carbamazepine, Estradiol); Drospirenone has 29 (also Atorvastatin, Omeprazole, Lamotrigine, Topiramate).

What mechanism field is on file for Felbamate and Drospirenone/Ethinyl Estradiol?

Felbamate can cause your body to process birth control hormones faster, which makes the pill less effective at preventing pregnancy.

Drospirenone's labeled portfolio outnumbers Felbamate

SPL source-record counts only. This page's band is minor · classes on file: Felbamate (Anticonvulsant); Drospirenone (Combined Oral Contraceptive).

Felbamate

1 major · 0 moderate · 15 minor · 16 total

Drospirenone

1 major · 0 moderate · 29 minor · 30 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.